Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
The Journal of Cell Biology|May 11, 2011
NPHP4, a cilia-associated protein, negatively regulates the Hippo pathwaySandra Habbig, Malte P Bartram, Roman U Müller, et al.
Human Molecular Genetics|October 3, 2012
The ciliopathy disease protein NPHP9 promotes nuclear delivery and activation of the oncogenic transcriptional regulator TAZSandra Habbig, Malte P Bartram, Josef G Sägmüller, et al.
Human Molecular Genetics|January 8, 2016
Three-layered proteomic characterization of a novel ACTN4 mutation unravels its pathogenic potential in FSGSMalte P Bartram, Sandra Habbig, Caroline Pahmeyer, et al.
The Journal of Biological Chemistry|June 20, 2008
Neph-Nephrin proteins bind the Par3-Par6-atypical protein kinase C (aPKC) complex to regulate podocyte cell polarityBjörn Hartleben, Heiko Schweizer, Pauline Lübben, et al.
Kidney International Reports|May 20, 2021
Expanding the Spectrum of FAT1 Nephropathies by Novel Mutations That Affect Hippo SignalingFrancesca Fabretti, Nikolai Tschernoster, Florian Erger, et al.
The Journal of Biological Chemistry|March 2, 2011
Nephrocystin-4 regulates Pyk2-induced tyrosine phosphorylation of nephrocystin-1 to control targeting to monociliaMax C Liebau, Katja Höpker, Roman U Müller, et al.
Human Molecular Genetics|January 22, 2016
The ubiquitin ligase Ubr4 controls stability of podocin/MEC-2 supercomplexesMarkus M Rinschen, Puneet Bharill, Xiongwu Wu, et al.
Science Signaling|April 13, 2017
YAP-mediated mechanotransduction determines the podocyte's response to damageMarkus M Rinschen, Florian Grahammer, Ann-Kathrin Hoppe, et al.
Kidney International Reports|February 5, 2024
Multicenter Long-Term Real World Data on Treatment With Lumasiran in Patients With Primary Hyperoxaluria Type 1Cristina Martin-Higueras, Lodovica Borghese, Armando Torres, et al.
Pageof 4